glp 1 neurodegenerative disease Repurposing glucagon-like peptide-1 receptor agonists for the treatment of disorders Anti-Inflammatory Effects of GLP-1 Receptor

Patients with overweight, obesity, or metabolic syndrome risk factors such as hyperglycemia and dyslipidemia, should be screened for NAFLD by starting with a liver enzyme panel If NAFLD is present, sustainable lifestyle modifications including therapeutic dietary and exercise interventions should be implemented with regular follow up assessments Adding nutritional bioactives, such as glutathione, should be considered American Liver Foundation

Efficacy and Safety of a Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Compared With its Components Given Alone: Results of a Phase 3, Open-Label, Randomised, 26-Week, Treat-to-Target Trial in Insulin-Naive Patients With Type 2 Diabetes

L-carnitine: more than just an alternative to glucose as an osmotic agent for peritoneal dialysis

Peroxisomal membrane ascorbate peroxidase is sorted to a membranous network that resembles a subdomain of the endoplasmic reticulum

Sepsis is known to impair pro-inflammatory immune response and increase some inflammatory and oxidative biomarkers in blood that spread throughout the world and is a major concern in ICU which has a significant mortality